11.10

6.41% -0.76

Neogenomics Inc (NEO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NEO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$11.86

Aprire:

$12.03

Volume 24 ore:

1.84M

Relative Volume:

2.18

Capitalizzazione di mercato:

$1.43B

Reddito:

$628.25M

Utile/perdita netta:

$-78.55M

Rapporto P/E:

-17.90

EPS:

-0.62

Flusso di cassa netto:

$-29.73M

1 W Prestazione:

-23.02%

1M Prestazione:

-21.72%

6M Prestazione:

-32.44%

1 anno Prestazione:

-32.65%

Intervallo 1D:

$10.90

$12.03

Intervallo di 1 settimana:

$10.69

$13.30

Portata 52W:

$10.69

$19.11

Neogenomics Inc Stock (NEO) Company Profile

Nome

Neogenomics Inc

Settore

Healthcare (1169)

Industria

Diagnostics & Research (60)

Telefono

(239) 768-0600

Indirizzo

9490 NEOGENOMICS WAY, FORT MYERS, FL

Dipendente

2,200

Cinguettio

@NeoGenomics

Prossima data di guadagno

2025-02-18

Ultimi documenti SEC

NEO's Discussions on Twitter

Confronta NEO con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NEO Neogenomics Inc	11.10	1.43B	628.25M	-78.55M	-29.73M	-0.62
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-13	Downgrade	The Benchmark Company	Buy → Hold
2024-12-10	Iniziato	Jefferies	Buy
2024-05-01	Ripresa	Craig Hallum	Buy
2023-12-29	Reiterato	BTIG Research	Buy
2023-08-21	Aggiornamento	Stephens	Equal-Weight → Overweight
2023-05-16	Downgrade	Raymond James	Outperform → Mkt Perform
2023-05-09	Aggiornamento	BTIG Research	Neutral → Buy
2023-02-24	Aggiornamento	The Benchmark Company	Hold → Buy
2023-02-01	Aggiornamento	Needham	Hold → Buy
2022-08-26	Downgrade	The Benchmark Company	Buy → Hold
2022-08-22	Downgrade	Needham	Buy → Hold
2022-06-03	Iniziato	Piper Sandler	Overweight
2022-03-29	Downgrade	BofA Securities	Buy → Neutral
2022-03-29	Downgrade	Stephens	Overweight → Equal-Weight
2022-01-18	Ripresa	Stephens	Overweight
2021-12-16	Iniziato	Cowen	Outperform
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-10-14	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-06-03	Iniziato	Goldman	Buy
2021-02-25	Ripresa	Needham	Buy
2021-02-25	Downgrade	Raymond James	Outperform → Mkt Perform
2021-01-28	Iniziato	Truist	Buy
2020-12-11	Ripresa	BTIG Research	Buy
2020-10-28	Reiterato	Needham	Buy
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-08-28	Iniziato	Guggenheim	Buy
2020-07-29	Reiterato	Needham	Buy
2020-06-25	Iniziato	BofA/Merrill	Buy
2020-04-21	Ripresa	Stephens	Overweight
2020-03-02	Ripresa	Craig Hallum	Buy
2020-02-28	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2020-01-23	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-30	Reiterato	Needham	Buy
2019-05-01	Reiterato	Needham	Buy
2019-03-29	Reiterato	Needham	Buy
2019-01-03	Iniziato	Needham	Buy
2018-10-24	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2018-08-21	Iniziato	Leerink Partners	Outperform
2018-05-02	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-09-11	Downgrade	BTIG Research	Buy → Neutral
2017-08-24	Iniziato	Gabelli & Co	Buy
2016-12-15	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Neogenomics Inc Borsa (NEO) Ultime notizie

Feb 21, 2025

NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance - MSN

Feb 21, 2025

Feb 20, 2025

Bank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat

Feb 20, 2025

NeoGenomics (NASDAQ:NEO) Price Target Cut to $18.00 by Analysts at Needham & Company LLC - MarketBeat

Feb 20, 2025

Feb 19, 2025

NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 - ACCESS Newswire

Feb 19, 2025

BTIG cuts Neogenomics price target to $17, maintains Buy rating - Investing.com India

Feb 19, 2025

BTIG cuts Neogenomics price target to $17, maintains Buy rating By Investing.com - Investing.com Canada

Feb 19, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call Transcript - MSN

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Sets New 52-Week Low After Earnings Miss - MarketBeat

Feb 19, 2025

Morgan Stanley cuts Neogenomics stock target to $17 from $18 By Investing.com - Investing.com Canada

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat

Feb 19, 2025

NeoGenomics price target lowered to $19 from $20 at TD Cowen - TipRanks

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Issues Earnings Results - MarketBeat

Feb 19, 2025

NeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025 - MSN

Feb 19, 2025